Atara Biotherapeutics Inc (ATRA)

Finanzdaten der Atara Biotherapeutics Inc-Aktie (ATRA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	22.09%0.63	0.52	1.60	3.45	17.58
	720.12%1.35	0.16	-0.22	-	-
Research and Development	720.12%1.35	0.16	-0.22	-	-
Interest Income/Expense	76.99%0.19	0.83	0.89	0.91	0.97
Costs And Expenses	37.71%5.35	3.89	4.16	7.03	14.38
Depreciation and Amortization	51.72%0.01	0.03	0.05	0.04	0.24
Operating Income/Loss	40.10%-4.72	-3.37	-2.56	-3.57	3.20
Income/Loss From Continuing Operations Before Tax	16.60%-4.83	-4.15	-3.41	-4.28	2.39
Income Tax Expense/Benefit	0.00	-	-	0.03	0.00
	16.62%-4.83	-4.15	-3.41	-4.30	2.39
Attributable To Parent	16.62%-4.83	-4.15	-3.41	-4.30	2.39
Basic Average Shares	6.76%15.03	14.08	-	13.56	12.20
Diluted Average Shares	6.76%15.03	14.08	-	13.56	12.31
Basic Earnings Per Share	10.34%-0.32	-0.29	-	-0.32	0.20
Diluted Earnings Per Share	10.34%-0.32	-0.29	-	-0.32	0.19